Project

Development of a novel mutation-agnostic therapy for PRPH2-associated inherited retinal diseases.

Code
DOCT/012946
Duration
13 January 2025 → 21 September 2025 (Ongoing)
Doctoral researcher
Research disciplines
No data available
 
Project description
No data available